OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
M7T$0.3057

Mach7 Technologies Ltd

Advanced Medical Equipment & TechnologyVerified

Mach7 Technologies Ltd has a market capitalization of approximately AUD 71.68 million, with a current market price of AUD 0.305 per share. The company's shares outstanding are 235,009,713, with no dilution observed between basic and diluted shares. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in the source documents. Profitability and returns data are not available for Mach7 Technologies Ltd, as the valuation snapshot does not include metrics such as return on invested capital (ROIC) or operating margins. Without these metrics, a direct comparison to industry peers and medians cannot be made. The company's segments and geographic exposure are not disclosed in the available data, making it difficult to assess revenue concentration or geographic diversification. Growth trajectory data is limited, as the outlook for the current and next fiscal years is not provided. Analysts have assigned a mean price target of AUD 0.62, with a median of AUD 0.62, indicating a potential upside from the current market price. Risk factors include the inability to assess liquidity risk due to missing balance-sheet data. The company is also flagged for potential liquidity risk, though the severity is not quantified. No dilution potential is indicated, as basic and diluted shares are equal. Recent events, such as filings or transcripts, are not disclosed in the available data, limiting insight into the company's recent strategic or operational developments.

30-day price · M7T-0.01 (-1.8%)
Low$0.25High$0.34Close$0.27As of13 May, 00:00 UTC
Profile
CompanyMach7 Technologies Ltd
TickerM7T.AX
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
AI analysis

Business. Mach7 Technologies Ltd provides healthcare equipment and technology solutions, primarily serving the healthcare services and equipment sector.

Classification. Mach7 Technologies Ltd is classified under the Healthcare sector, specifically in the Advanced Medical Equipment & Technology industry, with a classification confidence of 0.92.

Mach7 Technologies Ltd has a market capitalization of approximately AUD 71.68 million, with a current market price of AUD 0.305 per share. The company's shares outstanding are 235,009,713, with no dilution observed between basic and diluted shares. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in the source documents. Profitability and returns data are not available for Mach7 Technologies Ltd, as the valuation snapshot does not include metrics such as return on invested capital (ROIC) or operating margins. Without these metrics, a direct comparison to industry peers and medians cannot be made. The company's segments and geographic exposure are not disclosed in the available data, making it difficult to assess revenue concentration or geographic diversification. Growth trajectory data is limited, as the outlook for the current and next fiscal years is not provided. Analysts have assigned a mean price target of AUD 0.62, with a median of AUD 0.62, indicating a potential upside from the current market price. Risk factors include the inability to assess liquidity risk due to missing balance-sheet data. The company is also flagged for potential liquidity risk, though the severity is not quantified. No dilution potential is indicated, as basic and diluted shares are equal. Recent events, such as filings or transcripts, are not disclosed in the available data, limiting insight into the company's recent strategic or operational developments.
Key takeaways
  • Mach7 Technologies Ltd has a market capitalization of approximately AUD 71.68 million.
  • The company's shares outstanding are 235,009,713, with no dilution observed between basic and diluted shares.
  • Analysts have assigned a mean price target of AUD 0.62, suggesting potential upside from the current market price.
  • Liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in the source documents.
  • The company's profitability and returns data are not available, making it difficult to compare with industry peers.
  • # RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencyAUD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$19.0M-$10.7M-$9.4M$305.4k
FY-3$27.1M-$7.0M-$4.2M$4.5M
FY-2$30.5M-$7.0M-$1.0M$7.3M
FY-1$30.0M-$9.6M-$8.0M-$1.1M
FY0$34.6M-$7.7M-$6.2M-$656.6k
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$77.0M$57.9M$10.4M
FY-3$78.9M$58.4M$18.3M
FY-2$82.3M$59.5M$16.1M
FY-1$73.0M$51.9M$18.9M
FY0$64.2M$45.6M$17.3M
PeriodOCFCapExFCFSBC
FY-4$1.5M-$99.7k$305.4k
FY-3$6.4M-$438.6k$4.5M
FY-2-$2.6M-$361.0k$7.3M
FY-1$3.5M-$391.3k-$1.1M
FY0$868.6k-$1.7M-$656.6k
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price$0.30
Market cap$71.7M
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Healthcare Equipment · cohort 91 companies
MetricM7TActivity
Op margin-16.5% medp25 -174.5% · p75 8.8%
Net margin-16.5% medp25 -172.4% · p75 8.4%
Gross margin47.4% medp25 34.2% · p75 65.3%
CapEx / revenue-5.4% medp25 -12.5% · p75 -2.2%
Debt / equity4.3% medp25 0.0% · p75 28.0%
Observations
IR observations
Mean price target0.62 AUD
Median price target0.62 AUD
High price target0.80 AUD
Low price target0.44 AUD
Mean recommendation1.50 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate-0.02 AUD
Last actual EPS-0.03 AUD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 01:51 UTC#5d119b67
Market quoteclose AUD 0.28 · shares 0.24B diluted
no public URL
2026-05-12 01:51 UTC#0d560645
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 11:47 UTCJob: 4abf88be